Chapter 16. TNF-α converting enzyme (TACE) as a therapeutic target
- 1 January 2003
- book chapter
- Published by Elsevier BV in Annual Reports in Medicinal Chemistry
- Vol. 38, 153-162
- https://doi.org/10.1016/s0065-7743(03)38017-0
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Effect of tumor necrosis factor‐α converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neuronsJournal of Neurochemistry, 2002
- Phage Display of Functional Human TNF-α Converting Enzyme Catalytic Domain: A Rapid Method for the Production of Stabilized Proteolytic Proteins for Assay Development and High-Throughput ScreeningSLAS Discovery, 2002
- Process Development of a Dual MMP/TNF Inhibitor (SDZ 242-484)Organic Process Research & Development, 2002
- Synthesis and biological activity of selective pipecolic acid-based TNF-α converting enzyme (TACE) inhibitorsBioorganic & Medicinal Chemistry Letters, 2002
- Tumor necrosis factor-α converting enzymeThe International Journal of Biochemistry & Cell Biology, 2002
- Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-α converting enzymeBioorganic & Medicinal Chemistry Letters, 2001
- Design, Synthesis, and Structure−Activity Relationships of Macrocyclic Hydroxamic Acids That Inhibit Tumor Necrosis Factor α Release in Vitro and in VivoJournal of Medicinal Chemistry, 2001
- Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting EnzymePublished by Elsevier BV ,2000
- Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-α productionBioorganic & Medicinal Chemistry Letters, 1999
- Tumor Necrosis Factor: Function, Release and ClearanceCritical Reviews in Immunology, 1996